ras and c-myc protein expression in colorectal carcinoma |
| |
Authors: | Felice Miller M.D. Tomas M. Heimann M.D. Astrid Quish M.D. Daniel J. Pyo M.D. Arnold Szporn M.D. Giorgio Martinelli Ph.D. Thomas M. Fasy M.D. Ph.D. |
| |
Affiliation: | Department of Surgery, Mount Sinai School of Medicine, City University of New York, New York. |
| |
Abstract: | This study was performed to determine the correlation of tumor ras and c-myc oncogene expression with clinical and prognostic variables in patients prone to develop colorectal cancer. One hundred eighteen patients with colorectal cancer were studied; mean age was 40 years. Fifty-three were young patients (age 40 or less), 49 had ulcerative colitis, and 16 had multiple polyposis coli. Immunoperoxidase stains of paraffin-embedded cancer sections were performed for the c-myc and ras proteins. ras staining was found to correlate with Dukes stage and prognosis. Patients with tumors negative for ras protein stain had an actuarial five-year survival of 61 percent versus 44 percent for those tumors with a positive stain (P less than 0.05). This correlation was not seen with the c-myc stain. Positive ras oncogene stain appears to be a useful indicator of advanced stage and poor prognosis in colorectal cancer occurring in cancer-prone patients. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |